Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Aug 15, 2026; 18(8): 121785
Published online Aug 15, 2026. doi: 10.4251/wjgo.v18.i8.121785
Published online Aug 15, 2026. doi: 10.4251/wjgo.v18.i8.121785
Table 5 Comparison of postoperative complication rates between the two groups, n (%)
| Item | P group (n = 40) | R group (n = 40) | χ2/t value | P value |
| Postoperative agitation score, median (IQR) | 1.00 (1.00-2.00) | 2.00 (2.00-3.00) | -5.12 | < 0.001 |
| Postoperative agitation | 24 (60.00) | 4 (10.00) | 21.978 | < 0.001 |
| Delayed recovery | 0 (0.00) | 0 (0.00) | ||
| Postoperative delirium | 1 (2.50) | 0 (0.00) | 0 | 1 |
| Hypoxemia | 0 (0.00) | 0 (0.00) | ||
| Nausea and vomiting | 5 (12.50) | 8 (20.00) | 0.827 | 0.363 |
| MINS | 18 (45.00) | 6 (15.00) | 8.571 | 0.003 |
- Citation: Ma TT, Tong J, Liu MY. Cardioprotective effects of remimazolam in elderly hypertensive patients undergoing gastrointestinal tumor surgery: A randomized controlled trial. World J Gastrointest Oncol 2026; 18(8): 121785
- URL: https://www.wjgnet.com/1948-5204/full/v18/i8/121785.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i8.121785